Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301130023 | Category: Service & Software | Pages: 123 | Format: PDF | Published Date: February 13,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova and Siegfried, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Intermediate CDMO
    API CDMO
    Formulation CDMO
    Protein CDMO
    Gene Therapy CDMO
    Cell Therapy CDMO
Market segment by Application
    Pharmaceutical Company
    Biotechnology Company
    Generic Company
    Others
Market segment by players, this report covers
    Lonza
    Catalent
    Patheon (Thermo Fisher Scientific)
    Aenova
    Siegfried
    Recipharm
    Strides Shasun
    Piramal
    Metrics
    AMRI
    Famar
    WuXi AppTech
    Asymchem
    Porton
    Amatsigroup
    AcuraBio
    Moravek
    Ascendia Pharmaceuticals
    Ardena
    CPL
    Arranta Bio
    UPM Pharmaceuticals
    FUJIFILM Diosynth Biotechnologies
    Groupe Parima
    TBD Pharmatech
    Avid Bioservices
    Vetter Pharma
    NextPharma
    Alcami
    NerPharMa
    Vetio
    Societal CDMO
    ten23 health
    Piramal Pharma Solutions
    MedPharm
    Lundbeck
    AGC Pharma Chemicals
    BioVectra
    Pfizer CentreOne
    Jubilant Biosys
    SEIKAGAKU CORPORATION
    Mikart
    Adare Pharma Solutions
    Fermion
    Samsung Biologics
    Siegfried Holdings
    Boehringer Ingelheim
    Jubilant Pharmova Limited
    Fareva SA
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), with revenue, gross margin and global market share of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) from 2018 to 2023.
Chapter 3, the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization).
Chapter 13, to describe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) research findings and conclusion.

1 Market Overview_x000D_
    1.1 Product Overview and Scope of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)_x000D_
    1.2 Market Estimation Caveats and Base Year_x000D_
    1.3 Classification of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Type_x000D_
        1.3.1 Overview: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type: 2018 Versus 2022 Versus 2029_x000D_
        1.3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Type in 2022_x000D_
        1.3.3 Intermediate CDMO_x000D_
        1.3.4 API CDMO_x000D_
        1.3.5 Formulation CDMO_x000D_
        1.3.6 Protein CDMO_x000D_
        1.3.7 Gene Therapy CDMO_x000D_
        1.3.8 Cell Therapy CDMO_x000D_
    1.4 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market by Application_x000D_
        1.4.1 Overview: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application: 2018 Versus 2022 Versus 2029_x000D_
        1.4.2 Pharmaceutical Company_x000D_
        1.4.3 Biotechnology Company_x000D_
        1.4.4 Generic Company_x000D_
        1.4.5 Others_x000D_
    1.5 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecast_x000D_
    1.6 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast by Region_x000D_
        1.6.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region: 2018 VS 2022 VS 2029_x000D_
        1.6.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region, (2018-2029)_x000D_
        1.6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)_x000D_
        1.6.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)_x000D_
        1.6.5 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)_x000D_
        1.6.6 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)_x000D_
        1.6.7 Middle East and Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)_x000D_
2 Company Profiles_x000D_
    2.1 Lonza_x000D_
        2.1.1 Lonza Details_x000D_
        2.1.2 Lonza Major Business_x000D_
        2.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.1.4 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.1.5 Lonza Recent Developments and Future Plans_x000D_
    2.2 Catalent_x000D_
        2.2.1 Catalent Details_x000D_
        2.2.2 Catalent Major Business_x000D_
        2.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.2.4 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.2.5 Catalent Recent Developments and Future Plans_x000D_
    2.3 Patheon (Thermo Fisher Scientific)_x000D_
        2.3.1 Patheon (Thermo Fisher Scientific) Details_x000D_
        2.3.2 Patheon (Thermo Fisher Scientific) Major Business_x000D_
        2.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.3.5 Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans_x000D_
    2.4 Aenova_x000D_
        2.4.1 Aenova Details_x000D_
        2.4.2 Aenova Major Business_x000D_
        2.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.4.4 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.4.5 Aenova Recent Developments and Future Plans_x000D_
    2.5 Siegfried_x000D_
        2.5.1 Siegfried Details_x000D_
        2.5.2 Siegfried Major Business_x000D_
        2.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.5.4 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.5.5 Siegfried Recent Developments and Future Plans_x000D_
    2.6 Recipharm_x000D_
        2.6.1 Recipharm Details_x000D_
        2.6.2 Recipharm Major Business_x000D_
        2.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.6.4 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.6.5 Recipharm Recent Developments and Future Plans_x000D_
    2.7 Strides Shasun_x000D_
        2.7.1 Strides Shasun Details_x000D_
        2.7.2 Strides Shasun Major Business_x000D_
        2.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.7.4 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.7.5 Strides Shasun Recent Developments and Future Plans_x000D_
    2.8 Piramal_x000D_
        2.8.1 Piramal Details_x000D_
        2.8.2 Piramal Major Business_x000D_
        2.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.8.4 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.8.5 Piramal Recent Developments and Future Plans_x000D_
    2.9 Metrics_x000D_
        2.9.1 Metrics Details_x000D_
        2.9.2 Metrics Major Business_x000D_
        2.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.9.4 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.9.5 Metrics Recent Developments and Future Plans_x000D_
    2.10 AMRI _x000D_
        2.10.1 AMRI Details_x000D_
        2.10.2 AMRI Major Business_x000D_
        2.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.10.4 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.10.5 AMRI Recent Developments and Future Plans_x000D_
    2.11 Famar_x000D_
        2.11.1 Famar Details_x000D_
        2.11.2 Famar Major Business_x000D_
        2.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.11.4 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.11.5 Famar Recent Developments and Future Plans_x000D_
    2.12 WuXi AppTech_x000D_
        2.12.1 WuXi AppTech Details_x000D_
        2.12.2 WuXi AppTech Major Business_x000D_
        2.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.12.4 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.12.5 WuXi AppTech Recent Developments and Future Plans_x000D_
    2.13 Asymchem_x000D_
        2.13.1 Asymchem Details_x000D_
        2.13.2 Asymchem Major Business_x000D_
        2.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.13.4 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.13.5 Asymchem Recent Developments and Future Plans_x000D_
    2.14 Porton_x000D_
        2.14.1 Porton Details_x000D_
        2.14.2 Porton Major Business_x000D_
        2.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.14.4 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.14.5 Porton Recent Developments and Future Plans_x000D_
    2.15 Amatsigroup_x000D_
        2.15.1 Amatsigroup Details_x000D_
        2.15.2 Amatsigroup Major Business_x000D_
        2.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.15.4 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.15.5 Amatsigroup Recent Developments and Future Plans_x000D_
    2.16 AcuraBio_x000D_
        2.16.1 AcuraBio Details_x000D_
        2.16.2 AcuraBio Major Business_x000D_
        2.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.16.4 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.16.5 AcuraBio Recent Developments and Future Plans_x000D_
    2.17 Moravek_x000D_
        2.17.1 Moravek Details_x000D_
        2.17.2 Moravek Major Business_x000D_
        2.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.17.4 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.17.5 Moravek Recent Developments and Future Plans_x000D_
    2.18 Ascendia Pharmaceuticals_x000D_
        2.18.1 Ascendia Pharmaceuticals Details_x000D_
        2.18.2 Ascendia Pharmaceuticals Major Business_x000D_
        2.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.18.4 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.18.5 Ascendia Pharmaceuticals Recent Developments and Future Plans_x000D_
    2.19 Ardena_x000D_
        2.19.1 Ardena Details_x000D_
        2.19.2 Ardena Major Business_x000D_
        2.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.19.4 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.19.5 Ardena Recent Developments and Future Plans_x000D_
    2.20 CPL_x000D_
        2.20.1 CPL Details_x000D_
        2.20.2 CPL Major Business_x000D_
        2.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.20.4 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.20.5 CPL Recent Developments and Future Plans_x000D_
    2.21 Arranta Bio_x000D_
        2.21.1 Arranta Bio Details_x000D_
        2.21.2 Arranta Bio Major Business_x000D_
        2.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.21.4 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.21.5 Arranta Bio Recent Developments and Future Plans_x000D_
    2.22 UPM Pharmaceuticals_x000D_
        2.22.1 UPM Pharmaceuticals Details_x000D_
        2.22.2 UPM Pharmaceuticals Major Business_x000D_
        2.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.22.4 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.22.5 UPM Pharmaceuticals Recent Developments and Future Plans_x000D_
    2.23 FUJIFILM Diosynth Biotechnologies_x000D_
        2.23.1 FUJIFILM Diosynth Biotechnologies Details_x000D_
        2.23.2 FUJIFILM Diosynth Biotechnologies Major Business_x000D_
        2.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.23.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.23.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans_x000D_
    2.24 Groupe Parima_x000D_
        2.24.1 Groupe Parima Details_x000D_
        2.24.2 Groupe Parima Major Business_x000D_
        2.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.24.4 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.24.5 Groupe Parima Recent Developments and Future Plans_x000D_
    2.25 TBD Pharmatech_x000D_
        2.25.1 TBD Pharmatech Details_x000D_
        2.25.2 TBD Pharmatech Major Business_x000D_
        2.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.25.4 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.25.5 TBD Pharmatech Recent Developments and Future Plans_x000D_
    2.26 Avid Bioservices_x000D_
        2.26.1 Avid Bioservices Details_x000D_
        2.26.2 Avid Bioservices Major Business_x000D_
        2.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.26.4 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.26.5 Avid Bioservices Recent Developments and Future Plans_x000D_
    2.27 Vetter Pharma_x000D_
        2.27.1 Vetter Pharma Details_x000D_
        2.27.2 Vetter Pharma Major Business_x000D_
        2.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.27.4 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.27.5 Vetter Pharma Recent Developments and Future Plans_x000D_
    2.28 NextPharma_x000D_
        2.28.1 NextPharma Details_x000D_
        2.28.2 NextPharma Major Business_x000D_
        2.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.28.4 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.28.5 NextPharma Recent Developments and Future Plans_x000D_
    2.29 Alcami_x000D_
        2.29.1 Alcami Details_x000D_
        2.29.2 Alcami Major Business_x000D_
        2.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.29.4 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.29.5 Alcami Recent Developments and Future Plans_x000D_
    2.30 NerPharMa_x000D_
        2.30.1 NerPharMa Details_x000D_
        2.30.2 NerPharMa Major Business_x000D_
        2.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.30.4 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.30.5 NerPharMa Recent Developments and Future Plans_x000D_
    2.31 Vetio_x000D_
        2.31.1 Vetio Details_x000D_
        2.31.2 Vetio Major Business_x000D_
        2.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.31.4 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.31.5 Vetio Recent Developments and Future Plans_x000D_
    2.32 Societal CDMO_x000D_
        2.32.1 Societal CDMO Details_x000D_
        2.32.2 Societal CDMO Major Business_x000D_
        2.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.32.4 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.32.5 Societal CDMO Recent Developments and Future Plans_x000D_
    2.33 ten23 health_x000D_
        2.33.1 ten23 health Details_x000D_
        2.33.2 ten23 health Major Business_x000D_
        2.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.33.4 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.33.5 ten23 health Recent Developments and Future Plans_x000D_
    2.34 Piramal Pharma Solutions_x000D_
        2.34.1 Piramal Pharma Solutions Details_x000D_
        2.34.2 Piramal Pharma Solutions Major Business_x000D_
        2.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.34.4 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.34.5 Piramal Pharma Solutions Recent Developments and Future Plans_x000D_
    2.35 MedPharm_x000D_
        2.35.1 MedPharm Details_x000D_
        2.35.2 MedPharm Major Business_x000D_
        2.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.35.4 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.35.5 MedPharm Recent Developments and Future Plans_x000D_
    2.36 Lundbeck_x000D_
        2.36.1 Lundbeck Details_x000D_
        2.36.2 Lundbeck Major Business_x000D_
        2.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.36.4 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.36.5 Lundbeck Recent Developments and Future Plans_x000D_
    2.37 AGC Pharma Chemicals_x000D_
        2.37.1 AGC Pharma Chemicals Details_x000D_
        2.37.2 AGC Pharma Chemicals Major Business_x000D_
        2.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.37.4 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.37.5 AGC Pharma Chemicals Recent Developments and Future Plans_x000D_
    2.38 BioVectra_x000D_
        2.38.1 BioVectra Details_x000D_
        2.38.2 BioVectra Major Business_x000D_
        2.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.38.4 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.38.5 BioVectra Recent Developments and Future Plans_x000D_
    2.39 Pfizer CentreOne_x000D_
        2.39.1 Pfizer CentreOne Details_x000D_
        2.39.2 Pfizer CentreOne Major Business_x000D_
        2.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.39.4 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.39.5 Pfizer CentreOne Recent Developments and Future Plans_x000D_
    2.40 Jubilant Biosys_x000D_
        2.40.1 Jubilant Biosys Details_x000D_
        2.40.2 Jubilant Biosys Major Business_x000D_
        2.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions_x000D_
        2.40.4 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        2.40.5 Jubilant Biosys Recent Developments and Future Plans_x000D_
    2.41 SEIKAGAKU CORPORATION_x000D_
    2.42 Mikart_x000D_
    2.43 Adare Pharma Solutions_x000D_
    2.44 Fermion_x000D_
    2.45 Samsung Biologics_x000D_
    2.46 Siegfried Holdings_x000D_
    2.47 Boehringer Ingelheim_x000D_
    2.48 Jubilant Pharmova Limited_x000D_
    2.49 Fareva SA_x000D_
3 Market Competition, by Players_x000D_
    3.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Share by Players (2018-2023)_x000D_
    3.2 Market Share Analysis (2022)_x000D_
        3.2.1 Market Share of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Company Revenue_x000D_
        3.2.2 Top 3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players Market Share in 2022_x000D_
        3.2.3 Top 6 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players Market Share in 2022_x000D_
    3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Overall Company Footprint Analysis_x000D_
        3.3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Region Footprint_x000D_
        3.3.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint_x000D_
        3.3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint_x000D_
    3.4 New Market Entrants and Barriers to Market Entry_x000D_
    3.5 Mergers, Acquisition, Agreements, and Collaborations_x000D_
4 Market Size Segment by Type_x000D_
    4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value and Market Share by Type (2018-2023)_x000D_
    4.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast by Type (2024-2029)_x000D_
5 Market Size Segment by Application_x000D_
    5.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Application (2018-2023)_x000D_
    5.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast by Application (2024-2029)_x000D_
6 North America_x000D_
    6.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)_x000D_
    6.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)_x000D_
    6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country_x000D_
        6.3.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)_x000D_
        6.3.2 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        6.3.3 Canada Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        6.3.4 Mexico Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
7 Europe_x000D_
    7.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)_x000D_
    7.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)_x000D_
    7.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country_x000D_
        7.3.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)_x000D_
        7.3.2 Germany Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        7.3.3 France Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        7.3.4 United Kingdom Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        7.3.5 Russia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        7.3.6 Italy Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
8 Asia-Pacific_x000D_
    8.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)_x000D_
    8.2 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)_x000D_
    8.3 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region_x000D_
        8.3.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2029)_x000D_
        8.3.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        8.3.3 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        8.3.4 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        8.3.5 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        8.3.6 Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        8.3.7 Australia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
9 South America_x000D_
    9.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)_x000D_
    9.2 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)_x000D_
    9.3 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country_x000D_
        9.3.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)_x000D_
        9.3.2 Brazil Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        9.3.3 Argentina Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
10 Middle East & Africa_x000D_
    10.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)_x000D_
    10.2 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)_x000D_
    10.3 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country_x000D_
        10.3.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)_x000D_
        10.3.2 Turkey Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        10.3.3 Saudi Arabia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
        10.3.4 UAE Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)_x000D_
11 Market Dynamics_x000D_
    11.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers_x000D_
    11.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints_x000D_
    11.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Trends Analysis_x000D_
    11.4 Porters Five Forces Analysis_x000D_
        11.4.1 Threat of New Entrants_x000D_
        11.4.2 Bargaining Power of Suppliers_x000D_
        11.4.3 Bargaining Power of Buyers_x000D_
        11.4.4 Threat of Substitutes_x000D_
        11.4.5 Competitive Rivalry_x000D_
    11.5 Influence of COVID-19 and Russia-Ukraine War_x000D_
        11.5.1 Influence of COVID-19_x000D_
        11.5.2 Influence of Russia-Ukraine War_x000D_
12 Industry Chain Analysis_x000D_
    12.1 Pharmaceutical CDMO (Phar

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?